---
title: "RUMMELT ANDREAS — Ownership Dossier"
canonical: https://whiteintel.dev/entity/e7bc6321-e733-5791-84d9-ab7edef4a9e3
json: https://whiteintel.dev/api/public/dossier/e7bc6321-e733-5791-84d9-ab7edef4a9e3
identifier: sec:0001484986
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# RUMMELT ANDREAS

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001484986`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/e7bc6321-e733-5791-84d9-ab7edef4a9e3  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/e7bc6321-e733-5791-84d9-ab7edef4a9e3  

## Ownership & control

### Holdings / subsidiaries

- **ALEXION PHARMACEUTICALS INC** (director) — https://whiteintel.dev/entity/7842a64d-6d8c-59e1-82ea-575c4c24b5fa

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **RUMMELT ANDREAS**. Human view: https://whiteintel.dev/entity/e7bc6321-e733-5791-84d9-ab7edef4a9e3 · Structured JSON: https://whiteintel.dev/api/public/dossier/e7bc6321-e733-5791-84d9-ab7edef4a9e3._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._